Protocol No.: CV181058; A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin (BMS-477118) as Monotherapy in Pediatric Patients with Type 2 Diabetes

Project: Other project

StatusFinished
Effective start/end date8/17/128/16/14

Funding

  • Parexel International: $1,801.64